Using histopathology as the gold standard, the detection rate of PET/CT with 68Ga-PSMA-targeted agents was 63% in BR-PCa patients with a PSA < 2 ng/mL and 94% in BR-PCa patients with a PSA > 2.0 ng/mL [26]. This evidence concerns the gene KLK3 and posterior cortical atrophy.